We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
CLX Q1 Earnings Call Highlights Inflation and Margin Pressures
Read MoreHide Full Article
Key Takeaways
Clorox maintains fiscal 2027 sales growth guidance of 13-14% but expects EPS near the low end of its range.
CLX raised its annual input cost inflation estimate to $240 million and cut gross margin guidance to 41.5%.
Clorox targets margin recovery by selective pricing, productivity gains and $50M in GOJO cost synergies.
The Clorox Company (CLX - Free Report) faces mounting input cost pressures despite a stronger-than-expected start to fiscal 2027. Management maintained its annual sales and earnings guidance but revised margin expectations as commodity and transportation inflation intensified.
During the first-quarter fiscal 2027 earnings call, executives emphasized productivity improvements, targeted pricing, market share recovery and the integration of GOJO Industries. The company also outlined priorities ahead of its upcoming CEO (chief executive officer) transition.
Chief financial officer Luc Bellet reaffirmed fiscal 2027 net sales growth guidance of 13% to 14%, including approximately 9.5 percentage points from the GOJO acquisition. Organic sales are projected to increase 3.5% to 4.5%.
Adjusted earnings per share are expected between $5.7 and $6, although management now anticipates results closer to the lower end. Gross margin expectations were revised to approximately 41.5%.
First-quarter revenues increased 33% to $1.91 billion, exceeding the Zacks Consensus Estimate of $1.87 billion. Adjusted earnings of $1.55 per share surpassed the consensus estimate of 97 cents.
The Clorox Company Price, Consensus and EPS Surprise
Clorox Faces Rising Commodity and Transportation Costs
During questioning from UBS, Luc Bellet disclosed that anticipated annual input cost inflation increased to approximately $240 million, $40 million above the initial estimate.
Bellet identified resin, transportation and broader supply-chain expenses as significant contributors. Management expects inflationary pressures to be more pronounced during the first half of fiscal 2027.
First-quarter gross margin declined 130 basis points year over year to 40.4%. Management expects productivity improvements, revenue growth management initiatives and selective pricing to support margin recovery as the year progresses.
CLX Prioritizes Pricing and Productivity Improvements
CEO Linda Rendle emphasized balancing profitability recovery with improvements in brand competitiveness. The company has implemented targeted pricing across all four reporting segments.
During JPMorgan's questioning, Rendle highlighted a high-single-digit price increase for Glad Trash implemented in July. Additional selective pricing actions are being evaluated for the second half.
Bellet explained that productivity and cost savings will account for most margin recovery efforts. Longer-term priorities include restoring operating margins toward historical levels of approximately 18%, supported by productivity initiatives and benefits from the enterprise resource planning transformation.
Clorox Targets Market Share Gains Through Innovation
Rendle highlighted improving market share trends across several businesses, supported by merchandising execution and product innovation.
During TD Cowen's questioning, Rendle reported that Home Care gained more than half a percentage point of market share, while Hidden Valley gained nearly two points. Cat Litter remained an area requiring further improvement.
Management expects additional innovation launches during the second half of fiscal 2027. Rendle emphasized that consumer value-seeking behavior remains prevalent, reinforcing the importance of product superiority, targeted investments and effective promotional execution.
CLX Advances GOJO Integration and Synergy Opportunities
The integration of GOJO remains a central strategic priority. Clorox officially launched Clorox Purell ProCare, combining its professional cleaning operations with GOJO's capabilities.
During TD Cowen's questioning, Bellet indicated that the integration progress is accelerating. Management has visibility into the previously identified $50 million cost synergy opportunity, with some benefits arriving earlier than initially anticipated.
Bellet also explained that the acquisition's expected first-year adjusted earnings contribution has improved from approximately neutral to positive. Strong underlying business performance and accelerated integration savings supported that assessment.
Clorox Focuses on Execution Ahead of CEO Transition
Rendle reaffirmed the company's commitment to improving organic growth, strengthening product competitiveness and recovering profitability while managing elevated operating costs.
Rendle also discussed the transition to incoming CEO Fabian Garcia, scheduled for Jan. 5, 2027. Management emphasized continuity in strategic execution, with innovation, GOJO integration and productivity improvements remaining central priorities.
What CLX's Zacks Rank and Style Scores Indicate
CLX currently carries a Zacks Rank #4 (Sell), reflecting an unfavorable near-term earnings estimate revision outlook. Its Value, Growth and Momentum Scores of C indicate middle-range characteristics across all three investment styles.
The company's VGM Score of C also reflects a moderate combined profile. Under the Zacks framework, stocks with a Zacks Rank #1 (Strong Buy) or 2 (Buy) and a favorable A or B Style Score offer a more attractive combination of earnings revision trends and investment characteristics.
CLX's current ranking therefore signals caution despite its operating improvement initiatives. The Zacks Rank can change as analysts revise earnings estimates following the latest quarterly results and management's updated outlook.
View the Zacks #1 Rank List
Image: Bigstock
CLX Q1 Earnings Call Highlights Inflation and Margin Pressures
Key Takeaways
The Clorox Company (CLX - Free Report) faces mounting input cost pressures despite a stronger-than-expected start to fiscal 2027. Management maintained its annual sales and earnings guidance but revised margin expectations as commodity and transportation inflation intensified.
During the first-quarter fiscal 2027 earnings call, executives emphasized productivity improvements, targeted pricing, market share recovery and the integration of GOJO Industries. The company also outlined priorities ahead of its upcoming CEO (chief executive officer) transition.
CLX Maintains Guidance Despite Higher Cost Pressures
Chief financial officer Luc Bellet reaffirmed fiscal 2027 net sales growth guidance of 13% to 14%, including approximately 9.5 percentage points from the GOJO acquisition. Organic sales are projected to increase 3.5% to 4.5%.
Adjusted earnings per share are expected between $5.7 and $6, although management now anticipates results closer to the lower end. Gross margin expectations were revised to approximately 41.5%.
First-quarter revenues increased 33% to $1.91 billion, exceeding the Zacks Consensus Estimate of $1.87 billion. Adjusted earnings of $1.55 per share surpassed the consensus estimate of 97 cents.
The Clorox Company Price, Consensus and EPS Surprise
The Clorox Company price-consensus-eps-surprise-chart | The Clorox Company Quote
Clorox Faces Rising Commodity and Transportation Costs
During questioning from UBS, Luc Bellet disclosed that anticipated annual input cost inflation increased to approximately $240 million, $40 million above the initial estimate.
Bellet identified resin, transportation and broader supply-chain expenses as significant contributors. Management expects inflationary pressures to be more pronounced during the first half of fiscal 2027.
First-quarter gross margin declined 130 basis points year over year to 40.4%. Management expects productivity improvements, revenue growth management initiatives and selective pricing to support margin recovery as the year progresses.
CLX Prioritizes Pricing and Productivity Improvements
CEO Linda Rendle emphasized balancing profitability recovery with improvements in brand competitiveness. The company has implemented targeted pricing across all four reporting segments.
During JPMorgan's questioning, Rendle highlighted a high-single-digit price increase for Glad Trash implemented in July. Additional selective pricing actions are being evaluated for the second half.
Bellet explained that productivity and cost savings will account for most margin recovery efforts. Longer-term priorities include restoring operating margins toward historical levels of approximately 18%, supported by productivity initiatives and benefits from the enterprise resource planning transformation.
Clorox Targets Market Share Gains Through Innovation
Rendle highlighted improving market share trends across several businesses, supported by merchandising execution and product innovation.
During TD Cowen's questioning, Rendle reported that Home Care gained more than half a percentage point of market share, while Hidden Valley gained nearly two points. Cat Litter remained an area requiring further improvement.
Management expects additional innovation launches during the second half of fiscal 2027. Rendle emphasized that consumer value-seeking behavior remains prevalent, reinforcing the importance of product superiority, targeted investments and effective promotional execution.
CLX Advances GOJO Integration and Synergy Opportunities
The integration of GOJO remains a central strategic priority. Clorox officially launched Clorox Purell ProCare, combining its professional cleaning operations with GOJO's capabilities.
During TD Cowen's questioning, Bellet indicated that the integration progress is accelerating. Management has visibility into the previously identified $50 million cost synergy opportunity, with some benefits arriving earlier than initially anticipated.
Bellet also explained that the acquisition's expected first-year adjusted earnings contribution has improved from approximately neutral to positive. Strong underlying business performance and accelerated integration savings supported that assessment.
Clorox Focuses on Execution Ahead of CEO Transition
Rendle reaffirmed the company's commitment to improving organic growth, strengthening product competitiveness and recovering profitability while managing elevated operating costs.
Rendle also discussed the transition to incoming CEO Fabian Garcia, scheduled for Jan. 5, 2027. Management emphasized continuity in strategic execution, with innovation, GOJO integration and productivity improvements remaining central priorities.
What CLX's Zacks Rank and Style Scores Indicate
CLX currently carries a Zacks Rank #4 (Sell), reflecting an unfavorable near-term earnings estimate revision outlook. Its Value, Growth and Momentum Scores of C indicate middle-range characteristics across all three investment styles.
The company's VGM Score of C also reflects a moderate combined profile. Under the Zacks framework, stocks with a Zacks Rank #1 (Strong Buy) or 2 (Buy) and a favorable A or B Style Score offer a more attractive combination of earnings revision trends and investment characteristics.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
CLX's current ranking therefore signals caution despite its operating improvement initiatives. The Zacks Rank can change as analysts revise earnings estimates following the latest quarterly results and management's updated outlook.